Flushing away cocaine: New drug could be an anti-overdose first

A slight change to a naturally occurring enzyme means that chemists have created a molecule that could flush a cocaine overdose out of the body before it can cause irreparable damage to the central nervous system. more  

Risk of repeat attacks in heart patients causes concern for doctors

An international study, led by the University of Edinburgh, raises concerns that some patients may not be receiving the optimum medical treatment and follow-up care because doctors are misjudging the risk of a further heart attack. more

Antidepressants need new nerve cells to be effective, UT Southwestern researchers find

Researchers at UT Southwestern Medical Center have discovered in mice that the brain must create new nerve cells for either exercise or antidepressants to reduce depression-like behavior. more  

Endocrine Society releases guideline on diagnosis and treatment of primary aldosteronism

The Endocrine Society has released a new clinical practice guideline for the detection, diagnosis, and treatment of patients with primary aldosteronism. The guidelines appear in the September issue of the Journal of Clinical Endocrinology & Metabolism (JCEM), a publication of The Endocrine Society. more

Common treatment to delay labor decreases preterm infants' risk for cerebral palsy  

Intravenous magnesium sulfate supplementation before preterm delivery cuts the risk for handicapping cerebral palsy in half, according to research led by University of Alabama at Birmingham (UAB) obstetrician Dwight Rouse, M.D., and published in the Aug. 28 issue of The New England Journal of Medicine. more

Army personnel show increased risk for migraine: Condition underdiagnosed, mistreated 

Two new studies show that migraine headaches are very common among U.S. military personnel, yet the condition is frequently underdiagnosed. The studies, appearing in Headache, the peer-reviewed journal of the American Headache Society, examine the incidence among soldiers within 10 days of returning from a 1-year combat tour in Iraq , as well as U.S. Army officer trainees. more

Heart attack patients who stop statin risk death, say McGill researchers: Study finds doubled mortality risk if treatment is discontinued

Patients discontinuing statin medication following an acute myocardial infarction (AMI) increase their risk of dying over the next year, say researchers at McGill University and the McGill University Health Centre (MUHC). Their study was published in a recent issue of the European Heart Journal. more

© RAmEx Ars Medica,Inc. All rights reserved.

Information appearing on the Vidyya Medical News Service is not intended as a substitute for professional medical care. Seek professional medical help and follow your health care provider's advice.

Interested in subscribing to our daily e-mail newsletter? Send an email to Vidyya@Ramex.com with the word subscribe in the subject field.